Feed PYC.AX
PY
PYC Therapeutics Limited
PYC.AX · ASX
$2.15 +0.47% (+$0.01)
1M +32.10%
Market Cap $1.25B
P/E Ratio -
Div. Yield -
ROE 44.45%
Piotroski F-Score Weak
2/9Valuation
4 /100
Expensive P/B 7.39x
P/S 53.36x
PEG N/A
Growth
86 /100
Growing Book val. growth 62.73%
Rev. growth 13.56%
FCF growth N/A
Profitability
20 /100
Weak FCF margin 223.61%
Op. margin 228.26%
Gross margin 100.00%
Quality
2 /100
Poor Asset turnover 0.13x
ROA 27.45%
ROIC 16.84%
Debt
69 /100
Low Current ratio 14.41x
Int. coverage -861.87x
Debt/Equity 0.01x
Stability
37 /100
Moderate Profitable years 0
EPS volatility 514.98%
Beta 1.05x
Întreabă StockBot despre PYC.AX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rohan Hockings
Employees
37
Headquarters
Nedlands
Evenimente viitoare
27 AUG.
Earnings
Upcoming earnings report